Skip to main content
Log in

The Validation of an LC-MS Method for the Determination of Risperidone and its Active Metabolite 9-Hydroxyrisperidone in Human Plasma

  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

A simple, specific and sensitive high performance liquid chromatography-mass spectrometry (LC-MS) method for the determination of risperidone and its active metabolite 9-hydroxyrisperidone in human plasma has been developed and validated. The analytes were prepared through a single-step liquid-liquid extraction (LLE) procedure with the solvent methyl tert-butyl ether and quantitated by MS detection in the positive mode using selected ion monitoring (SIM). Each analytical run was completed within 9 min. Results showed that the LC-MS method enabled to detection of both compounds down to 0.1 ng.mL−1 (S/N > 3) and the linear range was 0.2–24 ng.mL−1, with the correlation coefficients above 0.99. At the concentration of 0.2, 0.5, 10 and 20 ng.mL−1, the inter-day and intra-day RSD were both below 15%. The method has been successfully used to support the routine therapeutic drug monitoring (TDM) and the pharmacokinetics study of risperidone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Chouinard G, Jones B, Remington G, Bloom D, Addington D, MacEwan GW, Labelle A, Beauclair L, Amott W (1993) J Clin Psychopharmacol 13:25

    CAS  Google Scholar 

  • Leysen JE, Gommeren W, Eens A, De Chaffoy de Courcelles D, Stoof JC, Jassen PA (1988) J Pharmacol Exp Ther 247:661

    CAS  Google Scholar 

  • Heykants J, Huang ML, Mannens G, Meuldermans W, Snoeck E, Vanbeijsterveldt L, VanpeerA, Woestenborghs R (1994) J Clin Psychiatry 55:513

    Google Scholar 

  • Mannens G, Human ML, Weuldermans W, Hendrickx J, Woestenborghs R, Heykants J (1993) Drug Metab Dispos 21:1134

    CAS  Google Scholar 

  • Huang ML, Van Peer A, Woestenborghs R, De Coster R., Heykants J, Zylicz A, Visscher H, Jonkman J (1993) Clin Pharmacol Ther 54:252

    Article  Google Scholar 

  • Van Beijsterveldt L, Geerts R, Leysen J, Megens A, Van den Eynde H, Meuldermans W, Heykants J (1994) Psychopharmacology 114:53

    Google Scholar 

  • Megents A, Awoutters F (1994) Drug Dev Res 33:399

    Google Scholar 

  • Woestenborghs R, Geuens I, Lenoir H, Janssen C, Heykants J, in: Reid E, Wilson ID (Eds), Methodological Surveys in Biochemistry and Analysis, (1990) Royal Society of Chemistry 20:241

    CAS  Google Scholar 

  • Nagasaki T, Ohkuo T, Sugawara K, Yasui N, Furukori H, Kaneko S (1999) J Chromatogr B 19:595

    CAS  Google Scholar 

  • Le Moing JP, Edouard S, Levron JC (1993) J Chromatogr 614:333

    Google Scholar 

  • Balant-Gorgia AE, Gex-Fabry M,Genent C, Balant LP (1998) Ther Drug Monit 21:105

    Google Scholar 

  • Remmerie BMM, Sips LLA, De Vries R., De Jong J, Schothuis AM, Hooijschuur EWJ (2003) J Chromatogr B 783:461

    CAS  Google Scholar 

  • Titier K, Bouchet S, Pehourcq F (2003) J Chromatogr B 788:179

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yunqiu Yu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, L., Jiao, Z., Yao, Z. et al. The Validation of an LC-MS Method for the Determination of Risperidone and its Active Metabolite 9-Hydroxyrisperidone in Human Plasma. Chroma 61, 245–251 (2005). https://doi.org/10.1365/s10337-005-0506-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1365/s10337-005-0506-y

Keywords

Navigation